Frontlight ResearchEarly access
Trial site
Barretos
- 11running trials
- 3closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers3 trials
- Lupus (SLE)3 trials
- Lung cancer2 trials
- ANCA-associated vasculitis1 trial
- Ankylosing spondylitis1 trial
- Chronic myeloid leukaemia1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Gastric and oesophageal cancer1 trial
- Glioblastoma1 trial
- Myeloproliferative neoplasms1 trial
- Neuroblastoma1 trial
- Neurofibromatosis type 11 trial
- and 2 more
- Phase
- Phase 36 trials
- Phase 25 trials
- Phase 43 trials
- Status
- Active, not recruiting8 trials
- Recruiting3 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals14 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Active, not recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Lupus (SLE)1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026